Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

Share Price is delayed by 15 minutes
Get Live Data
498.00    -16.00 (-3.11%)
Bid:
498.00
Ask:
506.00
Spread: 8.00 (1.606%)
Market Cap: £251.41m
FSJ Live PriceLast checked at - London Stock Exchange

Intraday James Fisher and Sons Share Chart

Trading update

25 Oct 2021 07:00

RNS Number : 0283Q
Fisher (James) & Sons plc
25 October 2021
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

25 October 2021

James Fisher and Sons plc

Trading update

James Fisher and Sons plc (FSJ.L) ('James Fisher', 'the Group'), the leading marine service provider, today publishes a trading update.

· Following a difficult start to the year, improvement in the Fendercare ship-to-ship transfer business remains below the rate previously expected, with some growing evidence of market shifts in some key territories.

· JFD has reached an impasse in negotiations over c.£2m due on a long-term project and is no longer forecasting a resolution in 2021.

· Customers of the Group's Marine Contracting, Decommissioning and Nuclear businesses have further delayed projects in recent weeks. The projects were previously expected to commence, and in some cases finish, in 2021. The continuing challenges presented by the global pandemic, particularly in the safe mobilisation of teams to work sites, have influenced customer decision-making processes.

· A recent deterioration in the condition of a financially distressed customer has increased bad debt risk by c.£2m.

· Tankships experienced a poor month in September and as a result has a more cautious outlook for the full year.

· Revenue in the quarter ended 30 September 2021 was 7.6% higher than Q3 2020 and 8.7% higher than Q2 of 2021. Year to date revenue is 3.9% below prior year.

· The Board now anticipates Underlying Operating Profit for the full year, before separately disclosed items, to be in the range of £27m - £32m.

The Group continues to trade within its banking covenants (which are formally measured at each half year end) and at 30 September had headroom of c.£100m against its revolving credit facilities.

In response to the latest short-term trading outlook, management is performing a detailed review of the Group's cost base and balance sheet. Aligned with the Board's commitment to 'fix or exit' non-core and underperforming businesses, the Group is continuing to advance at pace the divestment of non-core businesses and assets aimed at generating significant proceeds over the next year, to reduce net debt and financial leverage as well as to simplify the business.

Notwithstanding some revenue opportunity moving from Q4 2021 to 2022, the Board currently expects this to be materially offset by the continuation of challenges the Group is currently experiencing with customer demand and the safe mobilisation of teams to work sites.

The Board remains confident in the Group's strategy to deliver sustainable profitable growth from the significant market opportunities that are available to it and remains committed to executing on its long-term strategy.

Divisional Summary

Marine Support

The Fendercare ship-to-ship transfer business has continued to improve, but still not at the rate previously expected. There is growing evidence of market shifts in some key territories and the management team is conducting a detailed review of locations and trading partners to ensure that the business has the optimal mix of each.

Marine Contracting is trading ahead of prior year but has suffered from recent customer and weather delays that have pushed projects into H1 2022. Within our Renewables franchise EDS, the high voltage specialist, continues to perform well and has recently signed two multi-year, multi-million pound contracts with tier 1 contractors for monitoring services in Northern Europe, and more of these contracts remain in the sales pipeline. There has been no material change in the situation in Mozambique. The LNG projects remain suspended and dispute resolution discussions with our clients are ongoing. The Digital and Data Services businesses are in line with expectations and have strong order books.

Offshore Oil

The ScanTech businesses continue to perform well, showing strong growth over 2020 as demand for well-testing services, compressors and other asset rentals continues. ScanTech's bubble curtain offering to the Renewables market is continuing to see high demand with YTD revenue twice that achieved in the same period of 2020. RMSpumptools remains in line with expectations. The James Fisher Offshore business has experienced multiple delays to awarded projects and, following a recent deterioration in the condition of a financially distressed customer has increased bad debt risk of c.£2m. The most recent example being a customer delaying a multi-million dollar decommissioning project scheduled for Q4 2021 into 2022. Although frustrating, the order book is strong and demand for decommissioning services continues to show growth.

Specialist Technical

JFD's short-cycle diving equipment and training revenues remain soft, as previously announced, and are expected to remain so until well into 2022. In addition, the business has reached an impasse in negotiations over c.£2m due on a long-term project and is no longer forecasting a resolution in 2021.

The nuclear decommissioning business is in line with expectations at the end of Q3, however a major customer has unexpectedly deferred the award of new projects planned for Q4 2021 into 2022, leaving JFN with a shortfall for the remainder of the year. The business is focusing on short-term cost saving measures to mitigate the impact.

Tankships

Following a consistent trend of improvements in trading from February to August, the Tankships division experienced lower volumes of cargo and subdued market spot rates in September. It is not expected that the business will be able to recover the September shortfall and management has a more cautious outlook for the remainder of the year.

Group Revenue (unaudited)

£m

2020

2021

Quarter on quarter

variance

Cumulative variance

Q1

129.4

109.3

-15.5%

-15.5%

Q2

128.7

124.4

-3.3%

-9.5%

Q3

125.7

135.2

+7.6%

-3.9%

Q4

134.4

 

 

 

 

For further information

James Fisher and Sons plc

Eoghan O'Lionaird

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

020 7614 9508

FTI Consulting

Richard Mountain

 

020 3727 1340

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGGGUUPGPGC
Date   Source Headline
22nd May 202612:22 pmRNS-RNotice of Defence Division Investor Event
18th May 20269:30 amRNSDirector/PDMR Shareholding
13th May 20261:48 pmRNSResult of AGM
22nd Apr 202611:15 amRNSDirector/PDMR Shareholding
8th Apr 20269:28 amRNSAnnual Report and Accounts and Notice of AGM
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
16th Feb 20267:00 amRNSNotice of Analyst and Investor Presentations
13th Feb 20263:10 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
27th Jan 20262:05 pmRNSHolding(s) in Company
15th Jan 20262:00 pmRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20254:08 pmRNSHolding(s) in Company
26th Sep 20258:35 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSHalf Year Results
21st Aug 20257:00 amRNSNotice of Analyst and Investor Presentations
1st Aug 20258:00 amRNSTotal Voting Rights and Share Capital
29th Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
16th Jul 20257:00 amRNSTotal Voting Rights and Share Capital
16th Jun 20254:35 pmRNSBlock listing six monthly return
23rd May 202511:46 amRNSBlock Listing Application
13th May 20252:36 pmRNSResults of Annual General Meeting
6th May 202510:39 amRNSNotification of Directors' Interest in Shares
28th Apr 20252:33 pmRNSNotification of Directors' Interest in Shares
4th Apr 20259:30 amRNSAnnual Report and Accounts 2024 and Notice of AGM
20th Mar 20257:00 amRNSFull Year Results
14th Mar 20259:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20257:56 amRNSHolding(s) in Company
16th Jan 20259:58 amRNSHolding(s) in Company
16th Dec 202410:59 amRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Sep 20243:35 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSSigning of £95m of committed bank facilities
10th Sep 20247:00 amRNSHalf year results
6th Sep 20242:10 pmRNSCompletion of Disposal of Martek Holdings Limited
8th Jul 20244:19 pmRNSHolding(s) in Company
8th Jul 202410:04 amRNSCompletion of RMSpumptools Disposal
28th Jun 20249:26 amRNSDirector Declaration
17th Jun 202411:32 amRNSBlock listing six monthly return
13th Jun 20246:15 pmRNSResults of the General Meeting
12th Jun 20241:43 pmRNSNotification of Directors' Interests in Shares
30th May 20244:48 pmRNSResults of Annual General Meeting
30th May 20243:34 pmRNSDirector Declaration
24th May 20243:18 pmRNSPublication of Circular and Notice of GM
29th Apr 20245:39 pmRNSAnnual Report and Accounts 2023 and Notice of AGM
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.